Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2012.61
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

SALL1 Expression in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

Discovering Gene Expression Signatures Responding to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia

BMC Medical Genomics
Genetics
2016English

Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Deletion of SPRY4 Is a Frequent Event in Secondary Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2015English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Significance of Neuropilin-1 Expression in Acute Myeloid Leukemia

Turkish Journal of Haematology
Hematology
2013English

Expression Patterns of Immune Checkpoints in Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

Mechanism of Suppression of the Raf/Mek/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy